(The Consortium of Investigators of Modifiers of BRCA1/2)
Eligibility:
Any group that can contribute genotype and basic phenotype and epidemiological risk factor data from at least 92 BRCA1 and BRCA2 mutation
carriers can participate in CIMBA. Groups with smaller collections of carriers are encouraged to participate through partnership with a larger group
